Rayence Co., Ltd.

Equities

A228850

KR7228850004

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
8,610 ^KRW	-0.23%		+1.77%	-7.91%

Mar. 18	Rayence Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Rayence Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2023	CI

Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on May 10, 2018.

August 13, 2018 at 03:36 am EDT

From May 10, 2018 to June 30, 2018, the company has repurchased 232,066 shares, representing 1.43% for KRW 4,657.35 million. With this, the company has completed the repurchase of 232,066 shares, representing 1.43% for KRW 4,657.35 million under the buyback announced on May 10, 2018.

Latest news about Rayence Co., Ltd.

Rayence Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 17	CI
Rayence Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2023	Nov. 07	CI
Rayence Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
Rayence Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Rayence Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Rayence Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Rayence Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Rayence Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-14	CI
Rayence Launches 3D Inline AXI Detector, MIDAS 2121	21-06-07	CI
Rayence Co., Ltd.(KOSDAQ:A228850) dropped from S&P Global BMI Index	19-09-23	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on May 10, 2018.	19-05-14	CI
Rayence Co., Ltd.'s Equity Buyback announced on May 10, 2018, has expired with 449,782 shares, representing 2.8% for KRW 8,709.58 million.	18-10-30	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on May 10, 2018.	18-08-13	CI
Rayence Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.	18-05-10	CI
Rayence Co., Ltd. authorizes a Buyback Plan.	18-05-09	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on February 13, 2017.	18-02-13	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on February 13, 2017.	18-02-13	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on February 13, 2017.	18-02-13	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on February 13, 2017.	18-02-13	CI
Rayence Co., Ltd.'s Equity Buyback announced on February 13, 2017 has expired with 262,227 shares, representing 1.61% for KRW 4,992.22 million.	18-02-12	CI
Rayence Co., Ltd.‘s Equity Buyback announced on November 14, 2016, has expired.	17-11-13	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on February 13, 2017.	17-05-12	CI
Tranche Update on Rayence Co., Ltd.'s Equity Buyback Plan announced on November 14, 2016.	17-02-14	CI
Rayence Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	17-02-12	CI
Rayence Co., Ltd. authorizes a Buyback Plan.	17-02-12	CI

Chart Rayence Co., Ltd.

Duration

Period

More charts

Company Profile

Rayence Co., Ltd. is a Korea-based company mainly engaged in the manufacture of medical and veterinary X-ray detector products. Its products include thin film transistor (TFT) detectors and complementary-metal-oxide-semiconductor (CMOS) detectors. The products' brand name consists of 1012WCA, 17SCC/SGC, 1215CF, 1501CF and 0712CF. The Company also manufactures intra oral (I/O) sensors under the brand name of Ez1.0, Ez1.5, and mammography (mammo) machines under the brand 1724CM, 2434CM. The Company distributes its products to domestic and overseas markets.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Rayence Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8,610 KRW

Average target price

13,000 KRW

Spread / Average Target

+50.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
RAYENCE CO., LTD.	-7.91%	97.91M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.25%	15B
IRAY TECHNOLOGY COMPANY LIMITED	-38.91%	2.8B
SONOSCAPE MEDICAL CORP.	-12.68%	2.45B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-12.18%	1.46B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+43.80%	529M
GUERBET	+89.49%	504M
DETECTION TECHNOLOGY OYJ	+14.23%	245M
DRTECH CORPORATION	-19.37%	183M

Medical Imaging Systems